论文部分内容阅读
新加坡作者报告,用咪唑类新药——Ketoconazole与灰黄霉素比较治疗皮肤癣菌病,病原菌主要是须发癣菌、红发癣菌、絮状表皮癣菌。总共100例皮肤霉菌病成年患者(除外甲癣和念珠菌病患者及孕妇)等分成两组。Ketoconazole早餐前1次给200mg,灰黄霉素则在早餐后1次投给500mg,疗程4周。疗效标准:1.完全治愈:临床症状消失,霉菌检查及培养(-)。2.临床治愈:临床症状改善,
The authors of Singapore reported treatment of dermatophytosis with the new imidazole drug, ketoconazole, and griseofulvin. The pathogens are mainly Trichophyton mentagrophytes, Trichophyton rubrum, and Epidermophyton floccosum. A total of 100 adult patients with cutaneous mycosis (excluding onychomycosis and candidiasis and pregnant women) were divided into two groups. Ketoconazole 200mg once before breakfast, griseofulvin 500mg once after breakfast, for 4 weeks. Efficacy standards: 1. Completely cured: the disappearance of clinical symptoms, mold examination and culture (-). Clinical cure: clinical symptoms improved,